Other groups have also demonstrated that CD133+ HCC cells possess cancer stem cell-like properties, including self-renewal, differentiation, in vivo tumor initiation and chemotherapy resistance [12], [13], [14], [15]. This evidence concerns the gene PROM1 and cancer.